# Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

> **NCT00126308** · PHASE4 · TERMINATED · sponsor: **Kirby Institute** · enrollment: 100 (actual)

## Conditions studied

- HIV-Associated Lipodystrophy
- HIV Infections

## Interventions

- **DEVICE:** poly-L-lactic acid
- **DEVICE:** poly-L-lactic acid

## Key facts

- **NCT ID:** NCT00126308
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** no change in primary endpoint at week 48
- **Last updated:** 2009-04-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00126308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00126308, "Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00126308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*